The Bombay high court on Thursday said it was disheartened and disappointed with the Centre's insensitivity and with the Mumbai civic body for not starting door-to-door Covid-19 vaccination for senior citizens and specially-abled, bed-ridden and wheelchair-bound persons.
The Union Health Ministry has said in response to a Right to Information application that it does not know where records related to agenda circulated in meetings of the National Expert Group on Vaccine Administration for COVID-19 are held.
The Centre told the Bombay high court on Tuesday that a door-to-door COVID-19 vaccination programme for senior citizens, specially-abled, bed-ridden and wheelchair-bound people is currently not possible, but it has decided to start 'near-to-door' inoculation centres.
The Centre has said that on-site registration for COVID-19 inoculation for healthcare and frontline workers aged 18 to 44 years will now only be available at government COVID vaccination centres.
These decisions were taken by the ministry based on the fresh recommendations by The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and have also been communicated to the states and union territories, an official statement said.
This decision of revised time interval between two doses is applicable only to Covishield and not to Covaxin vaccine, the ministry said.
The Centre on Saturday directed the states and UTs that no fresh registrations of healthcare and frontline workers will be allowed since some ineligible beneficiaries were getting their names enlisted for vaccination against COVID-19, under this category, in violation of rules.
Chairperson of the COVID Task Force for All India Institute of Medical Sciences, Dr Naveet Wig on Thursday said that the COVID-19 crisis is 'a dynamic situation' and to prevent a third wave of the pandemic, there is a need to keep changing strategies.
"The concrete actions are a stern indication that Government of India is making all out efforts to increase vaccine production in the country as well as attracting foreign vaccine manufacturers to supply the required vaccine doses for national Covid vaccination programme," the ministry in a statement.
Union Health Minister Harsh Vardhan on Friday said the COVID-19 vaccination drive will be extended in the coming days and asserted that there should not be any misconceptions about the two Indian vaccines being administered in the country.
The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials.
India achieved this coverage in 130 days as against the USA's feat in 124 days.
Not enough data has been generated locally to decide on the need for a booster dose of COVID-19 vaccine for those fully inoculated, say experts amid the possibility of a third wave of the viral disease hitting the country between September and October.
According to officials, an additional dose of vaccine is different from a booster dose.
The Kerala high court has directed the Centre to allow scheduling, on CoWIN portal, of second Covishield dose after four weeks from the first for those who want to take it earlier than the present suggested gap of 84 days.
The decision empowers pregnant women to make an informed choice on taking the Covid vaccination, the ministry said, adding these women can now register on CoWIN or walk-in to the nearest Covid vaccination centre to get themselves inoculated.
Stressing on the need to protect both lives and livelihoods, he said public health action in India and across the world must be continually guided by evidence from four key questions -- how transmissible is the variant, severity of the disease it causes, how well vaccines and prior SARS-CoV-2 infection protect and how common people perceive risk and follow control measures.
'Better to prevent than to wait for evidence. Protection delayed can also mean protection denied'
Those intending to undertake international travel for education purposes, joining employment and as part of the Indian contingent to the Tokyo Olympics will be allowed to take the second dose of Covid vaccine Covishield prior to the prescribed time interval of 84 days after the first dose.
The Centre has written to states and Union Territories to immediately undertake necessary measures to include people aged 45 and above in the COVID-19 vaccination drive and stated that registration on the Co-WiN portal for the same would begin from April 1.
The Centre Thursday issued guidelines for vaccination near home, making it easier for the elderly and the differently-abled to get inoculated against coronavirus close to the places of their residence.
Modi tweeted that the meeting discussed important issues related to the progress of vaccine development, regulatory approvals and procurement.
There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.
The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programme within the country, the Union health ministry said.
Each state will plan it in two districts and preferably in five different session-type settings -- district hospital, community health centre or primary health care centre, urban site, private health facility and rural outreach.
In a statement, the PMO said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III. It further said Indian Scientists and research teams are collaborating and strengthening the research capacities in neighbouring countries such as Afghanistan, Bhutan, Bangladesh, Maldives, Mauritius, Nepal and Sri Lanka.
As India gears up to vaccinate people above 60 years of age and those over 45 years with comorbidities against COVID-19 from March 1, the Union health ministry on Friday said the facility of on-site registrations will be available so that eligible beneficiaries can walk into identified vaccination centres, get themselves registered and get inoculated.
The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
As the country eagerly awaits an expected coronavirus vaccination drive in January, at least 125 intended beneficiaries each in four states who had registered on the Co-WIN App were on Monday sent SMSes informing them about the time and place of their 'COVID-19 vaccination' under a mock-drill to administer the shots at designated centres.
In a statement, the Ministry of Home Affairs (MHA) said it has issued fresh guidelines for surveillance with regard to COVID-19 that will remain in force till January 31, as it asked the states and union territories to keep a strict vigil to prevent any rise in cases during the New Year celebrations and the winter season.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances